http://dermatologytimes.modernmedicine.com/dermatologytimes The Leading Newsmagazine for Dermatologists. Dermatology Times is a newsmagazine devoted to reporting timely information on the latest trends in the dermatology market. As such, it covers new procedures; advances in therapy, new products and drugs, the latest information presented at meetings, interviews with leaders in practice, academics and research. 2009-07-04T09:52:28Z http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/For-the-love-of-baseball-Dermatologist-carves-nich/ArticleStandard/Article/detail/607892?ref=25 Rany Jazayerli, M.D., has a thing for baseball and numbers. He was 3 years old when he told his father, a cardiologist, that he wanted to play professional baseball 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607892null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Avoiding-gridlock/ArticleStandard/Article/detail/607915?ref=25 Over the past few years, we have written many articles on potential strategies that a doctor can use to reduce income taxes, increase benefits or build retirement savings. In that time, we have also consulted with hundreds of medical groups on how to implement such strategies for their practice. Unfortunately, these consultations too often turn out to be less than fruitful because of office politics. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607915null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Not-fading-away-Hydroquinone-remains-on-market-but/ArticleStandard/Article/detail/607908?ref=25 Despite a rocky history and uncertain future, hydroquinone remains on the U.S. market as an excellent tool for the treatment of pigmentation issues, with new combinations offering more options 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607908null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Dollar-for-dollar-Maximize-your-tax-deferred-retir/ArticleStandard/Article/detail/607920?ref=25 If you're like most business owners and professionals, you think of every dollar as being the same as every other dollar. In truth, there are two kinds of dollars — before-tax dollars and after-tax dollars. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607920null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Laser+%26+Light+Technology+in+Dermatology+Top+Story/Marching-forward-Advances-in-laser-light-sources-b/ArticleStandard/Article/detail/607925?ref=25 Innovations in lasers and other light sources have opened up new options for treating patients with dark skin, according to a leading dermatologist. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607925null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Vulvar-ulcers-Patient-characteristics-lesion-morph/ArticleStandard/Article/detail/607919?ref=25 Vulvar ulcers are relatively easy to diagnose because there are just a few causes to consider. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607919null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Laser+%26+Light+Technology+in+Dermatology+Top+Story/Baby-steps-Laser-therapy-resolves-infantile-hemang/ArticleStandard/Article/detail/607897?ref=25 The first cutaneous use for lasers was on vascular lesions in the 1970s. Since that time, much has changed in the application of light therapy for these lesions. Infantile hemangiomas (IH) are now the most common tumors of infancy. Though many of these lesions seem clinically similar, all hemangiomas are not created equal. Many require immediate treatment in order to avoid complications 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607897null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis+Top+Story/Psoriasiss-changing-face-Therapies-understanding-o/ArticleStandard/Article/detail/607907?ref=25 Herakleitos, the Greek philosopher from Ephesus, once said, "Ta panta rei," which means "Everything changes and is in a state of flux." Perhaps no other quote better suits the ever-changing theories surrounding the nature, origin and cause of the dermatosis we call psoriasis. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607907null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Johnny-come-lately-Tardy-employees-can-impact-work/ArticleStandard/Article/detail/607900?ref=25 Patients who arrive late will test the daily schedule of a busy dermatology practice, but employees who show up late bring far more trouble. Tardy workers can drag down the morale of other employees, impede smooth workflow and hinder efforts to provide a good service experience to patients. Habitually late workers can even pose liability risks. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607900null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Underactive-thyroid-Atypical-clinical-symptoms-may/ArticleStandard/Article/detail/607895?ref=25 Atypical clinical symptoms can initially mask underlying disease, as seen in a recent case study of autoimmune hypothyroidism. Keeping an open mind when considering differential diagnoses is key to a reaching a quick diagnosis resulting in optimal patient management. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607895null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Medical-malpractice-Doctor-sued-for-negligence-aft/ArticleStandard/Article/detail/607893?ref=25 Dr. Skin has a large dermatology practice with an emphasis on psoriasis. Many of his fellow dermatologists refer their most difficult patients to him. In fact, Dr. Skin prides himself in his ability to manage these most difficult psoriatic patients. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607893null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Common-language-Merz-Scales-offer-common-language-/ArticleStandard/Article/detail/607917?ref=25 A recently developed photonumeric rating system aimed at objectively quantifying the severity of the outward signs of aging offers physicians, researchers and patients a common language with which to discuss the skin's aging process. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607917/vulvar_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Microsphere-based-5-FU-treatment-Multicenter-study/ArticleStandard/Article/detail/607903?ref=25 A multicenter, open-label study evaluated the efficacy and safety of a proprietary microsphere-based 0.5 percent 5-fluorouracil cream (Carac, Dermik) to treat actinic keratoses on multiple body sites. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607903null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Looking-to-the-future-Derms-foresee-changes-connec/ArticleStandard/Article/detail/607898?ref=25 Cosmetic dermatology procedures have dramatically changed the face of dermatology. Accutane, lasers, sunscreens, biologics, fillers and Botox are just a few of the additions made to the specialty's armamentarium throughout the past three decades. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607898null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Sky-high-SPFs-Dermatologists-debate-efficacy-of-ri/ArticleStandard/Article/detail/607922?ref=25 Although dermatologists see theoretical benefits in newer sunscreens with sun protection factors (SPFs) of up to 100 or more, some say the higher numbers confer no practical advantages over properly used products with lower ratings. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607922null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology-Times-Research-STAT-July-2009/ArticleStandard/Article/detail/607871?ref=25 This month's coverage includes: topical fluorouracil helps treat photoaging, macrophage marker linked to survival in melanoma, teledermatology could cut down on patient referrals, and more. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607871null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Conquering-keloids-New-therapies-offer-hope-to-pat/ArticleStandard/Article/detail/607911?ref=25 New treatment choices allow doctors to treat patients with keloids more effectively, an expert says. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607911null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Demonstrating-physician-competence-Do-continuing-m/ArticleStandard/Article/detail/607916?ref=25 I've been thinking about the issue of how to demonstrate physician competence for quite some time. I have long felt that the requirement for physicians to document their annual continuing medical education (CME) hours or to take recertifying examinations to renew their medical license was, at best, a faulty way to prove competence. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607916null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Informed-choices-Comparative-effectiveness-researc/ArticleStandard/Article/detail/607923?ref=25 A new comparative effectiveness research (CER) initiative designed to provide sound information to help patients and providers make informed treatment choices has been launched by the federal government, and it appears ready for inclusion in overall healthcare reform legislation moving through Congress. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607923null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Evolution-of-Mohs-General-surgerys-loss-is-dermato/ArticleStandard/Article/detail/607891?ref=25 Although invented by a general surgeon, Mohs micrographic surgery has become dermatology's gold standard for treating a variety of common nonmelanoma skin cancers. Indirectly, it has helped launch the fields of reconstructive surgery and æsthetic procedural dermatology, experts say. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607891null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Tradition-with-a-twist-Combination-approach-works-/ArticleStandard/Article/detail/607899?ref=25 For skin of color, melasma and postinflammatory hyperpigmentation are best treated with a combination approach, an expert says. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607899null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Subtle-shadings-Wide-range-of-skin-types-exists-am/ArticleStandard/Article/detail/607890?ref=25 There is a wide range of skin types among people of Latin descent. Thus, the term 'skin of color' is overly broad. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607890null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Hedgehog-inhibitor-Vitamin-D3-shows-promise-as-top/ArticleStandard/Article/detail/607912?ref=25 Research focusing on elucidating the molecular events involved in the Hedgehog (Hh) signaling pathway created interest in vitamin D3 as a chemopreventive agent for basal cell carcinoma (BCC), a tumor associated with aberrant Hh signaling. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607912null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Skin-toxicity-Preemptive-regimen-can-prevent-side-/ArticleStandard/Article/detail/607906?ref=25 Skin toxicity commonly occurs in accordance with the EGFR inhibitors cetuximab and panitumumab. It can often be prevented with a "preemptive" regimen, researchers say. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607906/skintoxicity_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/In-a-bind-New-compounds-interfere-with-inflammatio/ArticleStandard/Article/detail/607924?ref=25 The reduction of inflammation is important to a variety of skin diseases, as well as in the prevention of skin aging. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607924null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Vanquishing-vitiligo-Therapies-evolve-but-combinat/ArticleStandard/Article/detail/607909?ref=25 Advances in phototherapy and laser technology have helped improve vitiligo treatment results in recent years. Physicians may need to combine old and new therapies and be patient while waiting for improvement. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607909null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Lowering-the-risk-High-serum-levels-of-vitamin-D3-/ArticleStandard/Article/detail/607896?ref=25 Patients with the highest quintile levels of the active form of vitamin D (>30 ng/ml) in the blood had a 40 percent reduced risk of skin cancers compared with those in the lowest quintile (<16 ng/ml), according to a recent study. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607896null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/A-tribute-to-the-greats-Pioneers-defined-shaped-fi/ArticleStandard/Article/detail/607894?ref=25 Throughout history, many physicians and researchers have deservedly earned their place as pioneers and have helped to define and shape the field of dermatology. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607894null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Laser-hair-removal-Appropriate-device-careful-pati/ArticleStandard/Article/detail/607910?ref=25 Clinicians can avoid burning, blistering and discoloring skin when removing hair in patients of color by selecting appropriate laser therapy, an expert says. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607910null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Tanning-amp-teens-States-seek-to-bar-minors-from-u/ArticleStandard/Article/detail/607918?ref=25 With the rate of skin cancers on the rise among the general population, public health organizations, doctors and state lawmakers are mounting increasing efforts to regulate use of tanning salons by young people. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607918null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/The-blue-and-the-gray-Understanding-the-nature-of-/ArticleStandard/Article/detail/607914?ref=25 The American Civil War (1861-1865) is "inherently interesting," says Thomas G. Cropley, M.D., F.A.A.D., professor and chairman, department of dermatology, University of Virginia, Charlottesville, Va 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607914null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/A-fungus-among-us-Real-life-examples-provide-lesso/ArticleStandard/Article/detail/607904?ref=25 Recent case histories provide lessons in diagnosing and treating difficult fungal infections, an expert says. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607904null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Participation-counts-Battling-direct-billing-legis/ArticleStandard/Article/detail/607902?ref=25 Combating legislative proposals to ban indirect billing for dermatopathology services requires being well-prepared and highly vocal, according to a dermatologist who helped to counter such a proposal. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607902/participate_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Close-to-home-Teledermatology-eases-challenges-of-/ArticleStandard/Article/detail/607901?ref=25 Dermatology, which came of age as a medical specialty during the 20th century, continues to mature in the new millennium. Through modern technology, it is now possible for dermatologists to treat a host of tropical dermatoses and unusual cases without ever leaving the office. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607901null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Extensive-SCC-Unusual-case-poses-challenges-in-del/ArticleStandard/Article/detail/607926?ref=25 A young adult patient presented with an extensive forehead plaque of long-standing origin that was diagnosed by biopsy to be superficially invasive squamous cell carcinoma arising from actinic keratosis. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607926null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Differential-diagnosis-Histologic-features-of-amel/ArticleStandard/Article/detail/607921?ref=25 Amelanotic melanoma can have many varied, ambiguous histological features. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607921null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/360+Guide/360-Network--THE-GUIDE--July-2009/ArticleStandard/Article/detail/578281?ref=25 Interactive guide to clinical dermatology, practice management, managed care, and other physician topics available at modernmedicine.com 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/052009/578281null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Climate-watch-ISD-to-track-global-warmings-effects/ArticleStandard/Article/detail/607913?ref=25 One of the 21st century's most important medical issues is the effect of climate change on human health, according to the International Society of Dermatology (ISD), which plans to focus intensely on the issue in the coming years. 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607913null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/While-the-sun-shines-Debating-D-Study-sees-growing/ArticleStandard/Article/detail/607927?ref=25 The results of a recent study showing that blood levels of vitamin D are decreasing among Americans have rekindled the debate over how best to obtain vitamin D 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607927null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Out-from-the-shadows-Dermatology-emerged-as-a-disc/ArticleStandard/Article/detail/607905?ref=25 While the specialty was centuries from its beginning, the need for dermatologists was documented as early as in the Old Testament, when Job had an itch (Job 2:8). 2009-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607905null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Atopic+Dermatitis+%2F+Eczema/Dermatitis-flares-Consider-contact-sensitizers-whe/ArticleStandard/Article/detail/607075?ref=25 Physicians should always consider contact sensitizers to be one of the causes of flaring atopic dermatitis, as well as those cases recalcitrant to therapy. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607075null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Long-term-AK-clearance-Topical-imiquimod-outperfor/ArticleStandard/Article/detail/607167?ref=25 Analysis of a recent trial shows that topical imiquimod outperforms cryotherapy and topical 5-FU in terms of clinical and cosmetic outcomes in patients with actinic keratoses 12 months after treatment, an expert says. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607167null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Atopic+Dermatitis+%2F+Eczema/Pediatric-dermatitis-Efalizumab-succeeds-where-sta/ArticleStandard/Article/detail/607080?ref=25 Severe cases of atopic dermatitis can prove to be extremely challenging to effectively treat. Where other therapies fail, efalizumab may be one therapeutic option that can ultimately serve as the "go-to" therapy for those cases where standard therapies fall short of the mark. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607080null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/rsquoBlinking-lightrsquo-Actinic-keratoses-lesions/ArticleStandard/Article/detail/607194?ref=25 Actinic keratoses (AK) are lesions that have intermittent clinical expression, a fact that dermatologists should take into account when treating patients who have numerous AKs and extensive sun damage. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607194null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Atopic+Dermatitis+%2F+Eczema/Trichloracetic-acid-Unique-technology-can-achieve-/ArticleStandard/Article/detail/607148?ref=25 Many TCA peels are available on the market today but according to one expert, the Enerpeel with its unique technology can achieve superior cosmetic results and raises the bar in peeling treatments. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607148null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Web+Exclusive/The-curious-case-Odd-rare-and-abnormal-drug-reacti/ArticleStandard/Article/detail/607013?ref=25 Cleveland — Bent penis, black hairy tongue, ear ringing, nightmares and psoriasis are just some of the rare side effects of drugs commonly prescribed by dermatologists and other physicians. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607013null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Warning-MRSA-risks-rise-following-derm-surgery/ArticleStandard/Article/detail/607229?ref=25 The incidence of MRSA infections in dermatologic surgery appears to be on the rise. Dermatologic surgeons should respond to this increased risk by maintaining a higher level of suspicion and keep an eye out for those patients with a post-surgical infection that does not respond to standard antibiotic courses. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607229null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Multiple-AKs-and-SCCs-require-multifaceted-approac/ArticleStandard/Article/detail/607178?ref=25 Without definitive answers for treating large numbers of AKs and SCCs on the legs, an expert recommends trying multiple modalities while monitoring for invasive SCC. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607178null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Community-acquired-MRSA-Oral-doxycycline-highly-ef/ArticleStandard/Article/detail/607199?ref=25 Oral doxycycline has shown a high level of activity in treating community-acquired MRSA infections, and an enteric-coated formulation produces fewer gastrointestinal side effects than do uncoated formulations, an expert says. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607199null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Corticosteroid-lotion-Study-addresses-need-for-mor/ArticleStandard/Article/detail/607114?ref=25 An open-label study demonstrated the efficacy and safety of a four-week course of hydrocortisone butyrate lotion 0.1 percent (Locoid Lotion, Triax) for treating moderate-to-severe atopic dermatitis in pediatric patients ages 3 months to less than 18 years. Disease improvement was rapid and dramatic, and the safety evaluation included Cosyntropin Stimulation Testing. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607114null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Fighting-MRSA-New-cephalosporin-shows-potent-activ/ArticleStandard/Article/detail/607206?ref=25 Ceftaroline is a new beta-lactam cephalosporin that shows potent activity against MRSA in vitro and in human trials. 2009-06-29T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272009/607206null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Column/Money-matters-Consider-the-objectives-risks-charge/ArticleStandard/Article/detail/605786?ref=25 Q. I recently read in a study that over a ten-year period, the average investor lagged almost 11 percent behind the actual performance of the same mutual fund. How can this be? 2009-06-24T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262009/605786null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/National-Rosacea-Society-awards-new-grants-for-ros/ArticleStandard/Article/detail/604781?ref=25 Barrington, Ill. — The National Rosacea Society (NRS) announced that four new studies have been awarded funding as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially life-disruptive disorder now estimated to affect well over 14 million Americans. 2009-06-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252009/604781null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Medicis-now-shipping-Dysport/ArticleStandard/Article/detail/604367?ref=25 Scottsdale, Ariz. — Medicis has begun shipment to physicians of Dysport (abobotulinumtoxin A) for the treatment of glabellar lines. 2009-06-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/252009/604367null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Face-to-Face-Surgeonrsquos-memoir-details-historic/ArticleStandard/Article/detail/602715?ref=25 Cleveland — Cleveland Clinic surgeon Maria Siemionow, M.D., Ph.D., who led a team of doctors who performed the first near-total face transplant in the United States in late 2008, has written a book about the ground-breaking procedure. 2009-06-10T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242009/602715null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/HairDX-Launches-European-Subsidiary-To-Expand-Glob/ArticleStandard/Article/detail/602473?ref=25 International report — Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), pioneers of genetic tests for predicting the risk of male and female hair loss, today announced the launch of its European subsidiary, HairDX Europe. 2009-06-09T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242009/602473null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/FDA-approves-12-month-labeling-for-Evolence-collag/ArticleStandard/Article/detail/602196?ref=25 Ortho Dermatologics today announced that the U.S. Food and Drug Administration (FDA) approved a labeling supplement which includes efficacy and safety data through 12 months for EVOLENCE®, a collagen-based dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. 2009-06-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242009/602196null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Trimming-the-fat-End-overtime-use-mdash-and-abuse/ArticleStandard/Article/detail/602147?ref=25 If staff overtime is common in your dermatology practice, it?s time to take note. Overtime is costly, and can be abused. 2009-06-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242009/602147null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Public-supports-laws-to-help-protect-teens-from-ta/ArticleStandard/Article/detail/601452?ref=25 An overwhelming number of Americans believe young adults and children should not have access to tanning salons without parental oversight because of the danger of skin cancer, suggests an online poll by www.dermanetwork.org 2009-06-03T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601452null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/The-science-of-beauty-Institute-aims-to-decode-gen/ArticleStandard/Article/detail/600431?ref=25 Miami — A new, dermatologist-led institute at the University of Miami (UM) Miller School of Medicine aims to unravel the mysteries of how genetics and environment affect skin appearance. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600431/W6100.Bauman-injecting[1]_thumbnail.jpg http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600431null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Acne/Smoke-and-mirrors-Study-shows-relationship-between/ArticleStandard/Article/detail/599853?ref=25 Cigarette smokers are more likely to have severe acne when compared to non-smokers, according to the results of a recent study. Furthermore, abstinence from smoking may lead to significant improvements of acne lesions. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599853null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Clinical+Dermatology/Scarring-alopecia/ArticleStandard/Article/detail/599838?ref=25 Lichen planopilaris and pseudopelade of Brocq, both forms of scarring alopecia, appear to be two distinct conditions according to microarray analysis. There has been some suspicion that pseudopelade of Brocq is a variant of lichen planopilaris, but investigation of biopsies of the respective entities has failed to demonstrate this. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599838null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Acne/Acne-therapy-Unique-combination-gel-scores-high/ArticleStandard/Article/detail/599865?ref=25 A new adapalene-benzoyl peroxide fixed-dose combination gel proves very effective in the therapy of moderate acne and offers a powerful and unique approach in the treatment of patients with mild to moderate acne vulgaris. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599865null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Acne/BPO-gel-versus-wash-One-product-combination-has-qu/ArticleStandard/Article/detail/599872?ref=25 A study comparing the safety and efficacy of two acne combination therapies containing clindamycin, benzoyl peroxide and tretinoin showed that the regimen delivered in gel vehicles worked faster than the regimen that included a benzoyl peroxide wash, the study's author says. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599872null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Rosacea-and-ethnic-skin-Clinician-underappreciatio/ArticleStandard/Article/detail/599880?ref=25 Rosacea diagnosis in skin of color patients may depend on a careful examination and history. Disease management requires special considerations. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599880null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Clinical+Dermatology/Alefacept-for-the-treatment-of-chronic-severe-alop/ArticleStandard/Article/detail/599841?ref=25 A recent trial with alefacept proved to be ineffective in patients with severe alopecia areata, adding to the frustration in finding an effective therapy for this difficult to treat hair loss disease. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599841null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Acne/Blue-light-special-ALA-PDT-safe-effective-tool-for/ArticleStandard/Article/detail/599842?ref=25 A recent study shows that ALA-PDT can be effective in the treatment of acne and particularly beneficial for inflammatory lesions. This treatment modality offers clinicians a safe and effective tool in treating acne lesions without the worries associated with long-term antibiotic therapy and isotretinoin therapy. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599842null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Hope-for-rosacea-Cytokinin-treatment-offers-patien/ArticleStandard/Article/detail/599886?ref=25 A novel therapeutic approach with Pyratine-XR appears to be a helpful adjunct in the treatment of rosacea. This topical cytokine therapy offers patients another effective option for rosacea and is a much welcomed addition in the dermatologic armamentarium. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599886null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Pathogenesis-of-rosacea-Breakthroughs-hold-promise/ArticleStandard/Article/detail/599883?ref=25 Researchers have made exciting progress in delineating the pathogenesis of rosacea. The findings are expected to provide a basis for understanding factors associated with different rosacea subtypes and the identification of rational therapies. 2009-06-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/599883null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology-Times-Research-STAT-June-2009/ArticleStandard/Article/detail/600637?ref=25 This month's coverage includes: psoriasis associated with higher diabetes risk, phenol peels show benefit in treating skin conditions, and the feasibility of home UVB therapy for psoriasis patients. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600637null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/No-second-act-Raptiva-reintroduction-unlikely/ArticleStandard/Article/detail/600524?ref=25 Unlike Tysabri, which reemerged from a PML scare with a risk mitigation program, Raptiva won't return to the U.S. market, sources say. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600524null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Origin-and-development-Researchers-investigate-eti/ArticleStandard/Article/detail/600539?ref=25 Individuals with rosacea express abnormally high levels of cathelicidin in their facial skin. Researchers investigate how the proteolytically processed forms of cathelicidin peptides found in rosacea are different from those present in the general population. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600539null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Physician-insure-thyself-CICs-can-be-ideal-tools-i/ArticleStandard/Article/detail/601119?ref=25 As frequent speakers to physicians on asset protection and advanced planning, we are often asked about captive insurance companies (CICs). Certainly, CICs can be ideal tools if they are created for the right type of practice and are established and maintained properly. In this article, we will examine the benefits and costs of CICs and then demonstrate a case study of two doctors who use CICs to significantly enhance many areas of comprehensive financial planning. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601119null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Actinic-keratoses-have-intermittent-expression/ArticleStandard/Article/detail/600515?ref=25 Montreal ? Actinic keratoses (AKs) present with intermittent expression, even in patients with extensive damage, according to an 11-month study presented at the recent Society for Investigative Dermatology meeting. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600515null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Scientists-ID-molecules-responsible-for-melanoma-s/ArticleStandard/Article/detail/600519?ref=25 International report ? Researchers at the University of Nebraska Medical Center have discovered that a superfamily of molecules causes the progression and spread of melanoma. The study results are published in the British Journal of Cancer. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600519null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Psoriasis+Top+Story/Treating-psoriatic-arthritis-One-year-data-positiv/ArticleStandard/Article/detail/600526?ref=25 The investigational anti-tumor necrosis factor (TNF) monoclonal antibody golimumab (Centocor) is being evaluated as a once-a-month subcutaneous injection for the treatment of psoriatic arthritis in a Phase 3 trial that enrolled approximately 400 patients. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600526/psoriatic_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Living-antibiotic-free-New-acne-fighting-combinati/ArticleStandard/Article/detail/602140?ref=25 A newly approved acne medication that combines adapalene and benzoyl peroxide has shown safety and efficacy with daily use for up to one year and does not contribute to antibiotic resistance, a researcher says. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242009/602140null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Making-faces-Latest-transplant-operations-include-/ArticleStandard/Article/detail/600542?ref=25 Recipients of the world's fifth, sixth and seventh face transplants are doing well, their surgeons say. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600542null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Ounce-of-prevention-Low-dose-oral-isotretinoin-may/ArticleStandard/Article/detail/601117?ref=25 A recent study shows that oral isotretinoin is only slightly effective in the treatment of photoaging; however, the systemic retinoid proves to be significantly effective in the potential prevention of precancerous and cancerous skin lesions. According to one expert, dermatologists should carefully weigh the pros and cons of this drug before recommending it for chemoprevention. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601117null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Share-your-expertise-with-your-colleagues/ArticleStandard/Article/detail/600520?ref=25 Do you have a specific clinical pearl that you'd like to share with your colleagues? Dermatology Times wants to hear from you! 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600520null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Rejecting-common-wisdom-Red-scaly-faces-not-always/ArticleStandard/Article/detail/600543?ref=25 If you see a red, scaly face and think only rosacea or seborrheic dermatitis, you might be missing an important third condition — Demodex dermatitis 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600543null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Residual-SCC-Surgery-still-indicated-in-patients-w/ArticleStandard/Article/detail/601112?ref=25 An ongoing study shows that biopsy-confirmed Squamous cell carcinoma in situ lesions that appear tumor-free on clinical exam may still harbor residual disease. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601112null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Taking-stock-Invest-in-Americas-businesses-now-rea/ArticleStandard/Article/detail/601116?ref=25 For most business saving for retirement, the past year or so might be compared to a migraine headache that gets worse every day instead of getting better. For many of us, the big question has been whether to invest in the stock market at all during these troubled times. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601116null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/ALA-PDT-team-up-Combination-laser-therapy-proves-e/ArticleStandard/Article/detail/602138?ref=25 A novel treatment approach using ALA-PDT in combination with standard topical therapies proves to be very effective in treating mild-to-severe acne lesions. According to one expert, this combination approach can achieve a high clearance of acne lesions and may be a solution for treating acne lesions long term. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/242009/602138null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Leading-by-example-Derm-works-to-keep-order-in-hou/ArticleStandard/Article/detail/601237?ref=25 According to dermatologist Henry Lim, M.D., it is his personal values that define him professionally. "I try to look at the bigger picture. I try to be fair and nonjudgmental; try to lead, always, by example; and try to give back to the specialty," Dr. Lim tells Dermatology Times. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601237null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Skin-necrosis-Two-complications-of-anticoagulant-t/ArticleStandard/Article/detail/600527?ref=25 According to one expert, patients who develop heparin-induced thrombocytopenia should be closely monitored, as subsequent common administration of warfarin in order to maintain an anticoagulant status may result in warfarin-induced necrosis. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600527null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Out-from-under-the-knife-Therapies-available-to-tr/ArticleStandard/Article/detail/601110?ref=25 Whether using a scalpel, topical cream or other therapeutic approach, derms can treat cutaneous premalignant and malignant lesions effectively. Though topical modalities such as imiquimod have inferior total clearance rates when compared to surgical approaches, in certain situations, imiquimod can sometimes prove to be the treatment of choice. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601110null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Honing-healing-skills-Challenging-times-require-pe/ArticleStandard/Article/detail/600532?ref=25 Indeed, these are challenging economic times in the house of dermatology. We are challenged with personal financial pressures from evaporating retirement plans, caring for patients who have lost their health insurance due to job layoffs, and the rising costs of maintaining a practice. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600532null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AARS-announces-Acne-Awareness-Month/ArticleStandard/Article/detail/600518?ref=25 Hampton, N.H. ? The American Acne & Rosacea Society (AARS) has designated June 2009 as National Acne Awareness Month. The society hopes to educate healthcare providers about the treatment of acne through a series of live Webinars, according to a press release. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600518null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Excisions-and-repairs-Understand-the-coding-preven/ArticleStandard/Article/detail/601113?ref=25 Many revenue dollars are lost each year by dermatology providers because of misinformation they received regarding the coding of excisions and repairs, which came from a misinformed biller/coder in their office, a seminar they attended or information passed on by a colleague. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601113null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Maintaining-control-Effective-therapy-improves-qua/ArticleStandard/Article/detail/600535?ref=25 Ustekinumab (Centocor) pivotal trial data provide further evidence of the quality-of-life benefits derived when patients with moderate-to-severe psoriasis can maintain disease control. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600535null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Laser+%26+Light+Technology+in+Dermatology+Top+Story/The-power-of-light-Current-PDT-modalities-invaluab/ArticleStandard/Article/detail/600522?ref=25 Photodynamic therapy is extremely effective in the treatment of actinic keratosis, and in many ways, is surpassing other currently used treatment modalities; however, more studies need to be conducted in order to maximize PDT's therapeutic effects and increase patient tolerance, while minimizing adverse events, an expert says. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600522null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/The-eyes-have-it-Systemic-antibiotics-produce-resp/ArticleStandard/Article/detail/600523?ref=25 Systemic antibiotics at low or regular doses produce a response in patients with ocular rosacea, and additional therapies, such as sodium sulfacetamide eye drops or topical steroids, can also be administered. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600523null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Economic-credentialing-Policy-restricts-doctor-pat/ArticleStandard/Article/detail/600530?ref=25 Dr. Practice is a dermatologist in a local community that has been hit hard by the recession. He has staff privileges in a local hospital that has been a great referral system for his predominantly medical dermatology practice. In an attempt to increase revenues, Dr. Practice joins the staff of a nearby competing hospital. Immediately, he begins to see an increase in his patient referrals, both from the emergency room and staff of the new hospital. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600530null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Blues-for-Botox-Black-box-warning-slumping-economy/ArticleStandard/Article/detail/600534?ref=25 Though recent the stagnant economy combined with new competition and the FDA's mandate for stronger label warnings might appear to threaten Botox's dominance of the Aesthetic botulinum-toxin market, drugmaker Allergan doesn't appear overly concerned. Dermatologists — and at least one Wall Street analyst — seem to agree. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600534null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Myth-busters-Fat-dissolution-evidence-growing-slow/ArticleStandard/Article/detail/601114?ref=25 While the array of fat- and cellulite-melting devices — and the marketing hype behind them — continues to grow, these devices generally have yet to establish their safety and efficacy in tightly controlled studies, an expert says 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601114null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Chemoprevention-update-ALA-PDT-with-pre-treatment-/ArticleStandard/Article/detail/601118?ref=25 The treatment of actinic keratosis (AK) with ALA- and MAL-PDT is effective, and according to one expert, the combination of this modality with 5-FU before PDT achieves superior AK lesion clearance rates when compared to other treatments. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601118null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Essential-nutrients-Endogenous-antioxidant-found-i/ArticleStandard/Article/detail/601238?ref=25 Coenzyme Q10, also known as CoQ10 and ubiquinone, is an endogenous antioxidant. It is labeled ubiquinone because it is found in all cells and is both water- and oil-soluble. Coenzyme Q10 is not a necessary nutritional supplement because it is synthesized by the body — in contrast to vitamins. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/232009/601238null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Detecting-angiosarcoma-Case-study-underscores-impo/ArticleStandard/Article/detail/600521?ref=25 A quick and accurate diagnosis of angiosarcoma, followed by decisive treatment with a multidisciplinary approach can help avoid regional and distant metastases of the tumor and lead to a favorable prognosis, one expert says. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600521/detecting_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Now/Mind-over-matter-Psychosomatic-dermatology-provide/ArticleStandard/Article/detail/600525?ref=25 Psychosomatic dermatology involves considering the whole patient, and the possibility that dermatologic symptoms might have a mind-body origin, an expert says. 2009-06-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/222009/600525/brain_flash.jpg XML